PAMP
VERA icon

Polar Asset Management Partners’s Vera Therapeutics VERA Stock Holding History

Polar Asset Management Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-135,755
Closed -$1.86M – 914
2023
Q3 		$1.86M Sell
135,755
-126,600
-48% -$2.17M 0.04% 399
2023
Q2 		$4.21M Sell
262,355
-37,645
-13% -$340K 0.08% 328
2023
Q1 		$2.33M Sell
300,000
-114,000
-28% -$880K 0.04% 497
2022
Q4 		$8.01M Sell
414,000
-109,400
-21% -$1.98M 0.1% 287
2022
Q3 		$11.2M Buy
523,400
+229,100
+78% +$4.29M 0.13% 226
2022
Q2 		$4M Buy
294,300
+234,300
+391% +$4.09M 0.05% 548
2022
Q1 		$1.41M Buy
+60,000
New +$1.29M 0.02% 665

Other funds holding VERA

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Polar Asset Management Partners's VERA Position: Q4 2023 in Review

Polar Asset Management Partners sold out of Vera Therapeutics (VERA) in Q4 2023, closing a stake of 135,755 shares — an estimated $1.86M sold.

Polar Asset Management Partners first reported a position in VERA in Q1 2022 and held it in 7 quarters. The position peaked at $11.2M in Q3 2022. 95 funds tracked by Wall St. Rank hold VERA as of Q4 2023.

  • Polar Asset Management Partners reported no remaining Vera Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Polar Asset Management Partners sold 135,755 Vera Therapeutics shares in Q4 2023, an estimated $1.86M.
  • Polar Asset Management Partners first reported a position in Vera Therapeutics in Q1 2022 and held it in 7 quarters.
  • Polar Asset Management Partners's Vera Therapeutics position peaked at $11.2M in Q3 2022.
  • 95 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2023.

Based on Polar Asset Management Partners's 13F filing for Q4 2023, filed 14 Feb 2024.